tiprankstipranks
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
US Market

Lifecore Biomedical (LFCR) Financial Statements

Compare
134 Followers

Lifecore Biomedical Financial Overview

Lifecore Biomedical's market cap is currently $216.23M. The company's EPS TTM is $-0.584; its P/E ratio is ―; Lifecore Biomedical is scheduled to report earnings on April 2, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue$ 128.26M$ 103.27M$ 185.79M$ 544.16M$ 590.37M
Gross Profit$ 41.85M$ 27.29M$ 50.55M$ 81.47M$ 74.99M
Operating Income$ 9.33M$ -26.08M$ 3.46M$ -6.86M$ -8.30M
EBITDA$ 35.60M$ -35.98M$ 1.96M$ 13.00M$ -7.16M
Net Income$ 12.01M$ -102.19M$ -46.08M$ -32.66M$ -38.19M
Balance Sheet
Cash & Short-Term Investments$ 8.46M$ 19.09M$ 1.64M$ 1.29M$ 360.00K
Total Assets$ 273.70M$ 255.15M$ 295.44M$ 502.92M$ 541.31M
Total Debt$ 130.36M$ 112.74M$ 153.09M$ 221.40M$ 221.12M
Net Debt$ 121.90M$ 93.65M$ 151.45M$ 220.11M$ 220.76M
Total Liabilities$ 219.80M$ 256.99M$ 187.30M$ 300.14M$ 310.27M
Stockholders' Equity$ 53.90M$ -1.84M$ 108.14M$ 202.78M$ 231.04M
Cash Flow
Free Cash Flow$ -18.14M$ -55.22M$ -52.53M$ -8.75M$ -43.73M
Operating Cash Flow$ -217.00K$ -34.46M$ -24.40M$ 15.02M$ -17.04M
Investing Cash Flow$ -17.92M$ -4.15M$ 81.77M$ -10.86M$ -23.89M
Financing Cash Flow$ 7.51M$ 39.70M$ -57.02M$ -3.42M$ 40.02M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

Lifecore Biomedical Debt to Assets

Lifecore Biomedical Cash Flow

Lifecore Biomedical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis